share_log

Earnings Report: Satellite Chemical Co.,Ltd. Missed Revenue Estimates By 5.0%

Earnings Report: Satellite Chemical Co.,Ltd. Missed Revenue Estimates By 5.0%

收益報告:衛星化學公司, Ltd. 收入未達到預期5.0%
Simply Wall St ·  03/28 09:34

Shareholders might have noticed that Satellite Chemical Co.,Ltd. (SZSE:002648) filed its annual result this time last week. The early response was not positive, with shares down 3.4% to CN¥16.68 in the past week. Revenues came in 5.0% below expectations, at CN¥41b. Statutory earnings per share were relatively better off, with a per-share profit of CN¥1.42 being roughly in line with analyst estimates. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

股東們可能已經注意到衛星化學有限公司, Ltd.(深圳證券交易所:002648)上週這個時候公佈了年度業績。早期的反應並不樂觀,過去一週股價下跌3.4%,至16.68元人民幣。收入比預期低5.0%,爲410億元人民幣。法定每股收益相對較好,每股利潤爲1.42元人民幣,與分析師的估計大致一致。對於投資者來說,這是一個重要時刻,因爲他們可以在報告中追蹤公司的業績,看看專家對明年的預測,看看對該業務的預期是否有任何變化。根據這些結果,我們收集了最新的法定預測,以了解分析師是否改變了盈利模式。

earnings-and-revenue-growth
SZSE:002648 Earnings and Revenue Growth March 28th 2024
SZSE: 002648 收益和收入增長 2024 年 3 月 28 日

Taking into account the latest results, the current consensus from Satellite ChemicalLtd's twelve analysts is for revenues of CN¥47.4b in 2024. This would reflect a meaningful 14% increase on its revenue over the past 12 months. Per-share earnings are expected to jump 26% to CN¥1.79. Yet prior to the latest earnings, the analysts had been anticipated revenues of CN¥52.3b and earnings per share (EPS) of CN¥1.85 in 2024. It's pretty clear that pessimism has reared its head after the latest results, leading to a weaker revenue outlook and a small dip in earnings per share estimates.

考慮到最新業績,Satellite ChemicallTD的十二位分析師目前的共識是,2024年的收入爲474億元人民幣。這將反映其收入在過去12個月中大幅增長了14%。每股收益預計將增長26%,至1.79元人民幣。然而,在最新業績公佈之前,分析師曾預計2024年的收入爲523億元人民幣,每股收益(EPS)爲1.85元人民幣。很明顯,在最新業績公佈之後,悲觀情緒已經抬頭,導致收入前景疲軟,每股收益預期小幅下降。

Despite the cuts to forecast earnings, there was no real change to the CN¥20.68 price target, showing that the analysts don't think the changes have a meaningful impact on its intrinsic value. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic Satellite ChemicalLtd analyst has a price target of CN¥25.06 per share, while the most pessimistic values it at CN¥17.30. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

儘管下調了預期收益,但20.68元人民幣的目標股價沒有實際變化,這表明分析師認爲這些變化不會對其內在價值產生有意義的影響。但是,固定單一價格目標可能是不明智的,因爲共識目標實際上是分析師目標股價的平均值。因此,一些投資者喜歡查看估計範圍,看看對公司的估值是否有任何分歧。最樂觀的Satellite ChemicalLTD分析師將目標股價定爲每股25.06元人民幣,而最悲觀的分析師則將其估值爲17.30元人民幣。如你所見,分析師對該股的未來並不完全一致,但估計範圍仍然相當狹窄,這可能表明結果並非完全不可預測。

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that Satellite ChemicalLtd's revenue growth is expected to slow, with the forecast 14% annualised growth rate until the end of 2024 being well below the historical 34% p.a. growth over the last five years. Compare this to the 484 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 17% per year. So it's pretty clear that, while Satellite ChemicalLtd's revenue growth is expected to slow, it's expected to grow roughly in line with the industry.

了解這些預測的更多背景信息的一種方法是研究它們與過去的業績相比如何,以及同一行業中其他公司的表現。我們要強調的是,Satellite ChemicallTD的收入增長預計將放緩,預計到2024年底的年化增長率爲14%,遠低於過去五年來歷史上34%的年增長率。相比之下,該行業中其他484家擁有分析師報道的公司,預計這些公司的收入將以每年17%的速度增長。因此,很明顯,儘管Satellite ChemicallTD的收入增長預計將放緩,但預計其增長將與行業大致持平。

The Bottom Line

底線

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. They also downgraded their revenue estimates, although as we saw earlier, forecast growth is only expected to be about the same as the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

要了解的最重要的一點是,分析師下調了每股收益的預期,這表明公佈這些業績後,市場情緒明顯下降。他們還下調了收入預期,儘管正如我們之前看到的那樣,預計增長僅與整個行業大致相同。共識目標股價沒有實際變化,這表明該業務的內在價值與最新估計相比沒有發生任何重大變化。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Satellite ChemicalLtd analysts - going out to 2026, and you can see them free on our platform here.

話雖如此,公司收益的長期軌跡比明年重要得多。多位Satellite ChemicallTD分析師估計,到2026年,你可以在我們的平台上免費查看。

You still need to take note of risks, for example - Satellite ChemicalLtd has 1 warning sign we think you should be aware of.

你仍然需要注意風險,例如——Satellite ChemicallTD有1個我們認爲你應該注意的警告信號。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論